We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$156B
AUM Growth
-$21.1B
(-12%)
Cap. Flow
-$19.2B
Cap. Flow
% of AUM
-12.28%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
2,506
New
88
Increased
1,137
Reduced
1,110
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$697M |
| 2 |
ASML
ASML
|
+$575M |
| 3 |
CRH
CRH
|
+$473M |
| 4 |
ServiceNow
NOW
|
+$442M |
| 5 |
Meta Platforms (Facebook)
META
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.65B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$977M |
| 4 |
Apple
AAPL
|
+$923M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$843M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Financials | 11.5% |
| 3 | Industrials | 11.05% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Healthcare | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Ocular Therapeutix
OCUL
$1.92B
| $191K | ﹤0.01% |
22,528
+1,011
| +5% | +$9.64K |
|
2177
BigBear.ai
BBAI
$1.38B
| $190K | ﹤0.01% |
53,876
+4,170
| +8% | +$19.4K |
|
2178
Eos Energy Enterprises
EOSE
$1.25B
| $189K | ﹤0.01% |
38,034
+1,748
| +5% | +$18.8K |
|
2179
nCino
NCNO
$1.92B
| $188K | ﹤0.01% |
12,550
-82
| -0.6% | -$1.54K |
|
2180
Cellebrite
CLBT
$3.65B
| $183K | ﹤0.01% |
13,310
+163
| +1% | +$2.46K |
|
|
HAPN
2181
Happen Inc
HAPN
$2.14B
| $182K | ﹤0.01% |
12,743
-139
| -1% | -$2.33K |
|
2182
Wave Life Sciences
WVE
$1.15B
| $180K | ﹤0.01% |
24,793
+9,072
| +58% | +$118K |
|
2183
Akebia Therapeutics
AKBA
$349M
| $180K | ﹤0.01% |
129,170
-121,367
| -48% | -$167K |
|
2184
Hertz
HTZ
$590M
| $179K | ﹤0.01% |
38,765
-400,143
| -91% | -$1.94M |
|
2185
Babcock & Wilcox
BW
$1.43B
| $178K | ﹤0.01% |
12,137
+70
| +0.6% | +$736 |
|
2186
QuidelOrtho
QDEL
$1.14B
| $177K | ﹤0.01% |
10,764
+850
| +9% | +$20.9K |
|
|
TRTX
2187
TPG RE Finance Trust
TRTX
$673M
| $174K | ﹤0.01% |
22,235
-119
| -0.5% | -$1.02K |
|
2188
Evolution Petroleum
EPM
$134M
| $172K | ﹤0.01% |
37,474
| – | – |
|
2189
Trump Media & Technology Group
DJT
$2.53B
| $168K | ﹤0.01% |
18,157
-483
| -3% | -$5.55K |
|
2190
Atlas Energy Solutions
AESI
$1.47B
| $166K | ﹤0.01% |
12,641
-31
| -0.2% | -$362 |
|
2191
Recursion Pharmaceuticals
RXRX
$1.63B
| $164K | ﹤0.01% |
53,269
+3,611
| +7% | +$14K |
|
2192
Liberty Latin America Class C
LILAK
$1.54B
| $163K | ﹤0.01% |
20,299
-165
| -0.8% | -$1.18K |
|
2193
Marqeta
MQ
$1.85B
| $163K | ﹤0.01% |
9,969
-411
| -4% | -$6.92K |
|
2194
Ardelyx
ARDX
$1.29B
| $161K | ﹤0.01% |
26,885
+2
| +0% | +$13 |
|
|
PMT
2195
PennyMac Mortgage Investment
PMT
$854M
| $160K | ﹤0.01% |
13,741
-104
| -0.8% | -$1.28K |
|
2196
Ecovyst
ECVT
$1.36B
| $159K | ﹤0.01% |
12,384
-550
| -4% | -$6.21K |
|
2197
Vir Biotechnology
VIR
$1.51B
| $158K | ﹤0.01% |
17,689
+2,717
| +18% | +$21.6K |
|
2198
Energy Services of America
ESOA
$297M
| $158K | ﹤0.01% |
12,002
-51,508
| -81% | -$606K |
|
2199
Capitol Federal Financial
CFFN
$1.07B
| $157K | ﹤0.01% |
22,057
+4,115
| +23% | +$29.3K |
|
|
STUB
2200
StubHub Holdings
STUB
$3.18B
| $156K | ﹤0.01% |
25,060
-280,890
| -92% | -$2.92M |
|
Similar funds
Victory Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Victory Capital Management held 2,506 positions worth $156B, down 12% from $177B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Victory Capital Management withdrew a net $19.2B in Q1 2026, closing 97 positions and reducing 1,110 holdings. Its most notable exit was iShares MSCI Emerging Markets ex China ETF, an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Victory Capital Management opened a new position in Amrize Ltd worth $218M.
- Victory Capital Management's largest Q1 2026 buy was Amrize Ltd: 3,886,958 shares worth $218M.
- Victory Capital Management added most to Accenture in Q1 2026, an estimated $697M increase.
- Victory Capital Management's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.65B.
- Victory Capital Management fully exited iShares MSCI Emerging Markets ex China ETF in Q1 2026, selling an estimated $136M.
- Victory Capital Management's ten largest holdings make up 18% of its $156B portfolio in Q1 2026.
- Victory Capital Management opened 88 new positions and closed 97 in Q1 2026.
- Victory Capital Management's portfolio value fell 12% quarter-over-quarter to $156B.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.